1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Moldova Pharmaceuticals and Healthcare Report Q1 2016

Moldova Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 86 pages

Includes 3 FREE quarterly updates

BMI View: The Moldovan pharmaceutical market represents a small opportunity within Eastern Europe,given the total market size and reliance of the market on out-of-pocket payments Moldova's economicoutlook, which is defined by its relations with Russia and the EU, will play a significant role in how themarket grows over the coming years

Headline Expenditure Projections

- Pharmaceuticals: MDL553bn (USD394mn) in 2014 to MDL583bn (USD333mn) in 2015; +55% inlocal currency terms and -153% in US dollar terms

- Healthcare: MDL1287bn (USD916mn) in 2014 to MDL1386bn (USD792mn) in 2015; +77% in localcurrency terms and -136% in US dollar terms

Table Of Contents

Moldova Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Moldova 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Moldova 2011-2019) 13
Healthcare Market Forecast 14
Table: General Government Budget, 2008-2016 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2011-2019) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2011-2019) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Moldova 2011-2019) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Moldova 2011-2019) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Moldova 2011-2019) 23
OTC Drug Market Forecast | 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Moldova 2011-2019) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Moldova 2013-2019) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Moldova 2013-2019) 29
Industry Risk Reward Index 30
Central And Eastern Europe Risk/Reward Index - Q1 2016 30
Moldova Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Intellectual Property Issues 41
Pricing Regime 42
Reimbursement Regime 43
International Trade Agreements 44
Market Overview 45
Healthcare Sector 45
Table: Public Healthcare Expenditure, 2007-2011 46
Research And Development 48
Clinical Trials 49
Epidemiology 50
Table: 10 Most Frequent Causes of Death*, 2012 52
Table: Leading Causes Of Morbidity, % Of Total Disease Burden 52
Competitive Landscape 54
Research-Based Industry 54
Table: Multinational Market Activity 56
Pharmaceutical Distribution 57
Pharmaceutical Retail Sector 58
Company Profile 59
Farmaco (Pharmaco) 59
Gedeon Richter 62
GlaxoSmithKline 65
Novartis (Sandoz) 67
Pfizer 69
Sanofi 71
Top Pharm 73
Demographic Forecast 75
Table: Population Headline Indicators (Moldova 1990-2025) 76
Table: Key Population Ratios (Moldova 1990-2025) 76
Table: Urban/Rural Population and Life Expectancy (Moldova 1990-2025) 77
Table: Population By Age Group (Moldova 1990-2025) 77
Table: Population By Age Group % (Moldova 1990-2025) 78
Glossary 80
Methodology 82
Pharmaceutical Expenditure Forecast Model 82
Healthcare Expenditure Forecast Model 82
Notes On Methodology 83
Risk/Reward Index Methodology 84
Index Overview 85
Table: Pharmaceutical Risk/Reward Index Indicators 85
Indicator Weightings 86

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


Download Unlimited Documents from Trusted Public Sources

Generic Drug Industry in the US

  • September 2016
    9 pages
  • Generic Drug  

  • United States  

View report >

Opioid and Therapy Market in the US

  • September 2016
    11 pages
  • Opioid  

    Therapy  

    Analgesic  

  • United States  

View report >

Opioid Market in the US

  • September 2016
    13 pages
  • Opioid  

    Anesthetics  

    Analgesic  

  • United States  

View report >

Related Market Segments :

Pharmaceutical
Healthcare

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.